Onconic Therapeutics Inc. Logo

Onconic Therapeutics Inc.

Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.

476060 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로26길 12 제일비젼타워 11층, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Onconic Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative drugs for cancer and gastrointestinal diseases. A subsidiary of Jeil Pharmaceutical, the company focuses on therapeutic areas with high unmet medical needs and significant market potential. Its development pipeline features novel treatments for acid-related conditions, including ZacuCorrection (zastaprazan), a next-generation potassium-competitive acid blocker (P-CAB) designed to treat gastroesophageal reflux disease. Onconic Therapeutics aims to advance its portfolio through clinical development and strategic collaborations to bring new therapeutic options to patients.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Onconic Therapeutics Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 00:00
Share Issue/Capital Change
주권매매거래정지 (무상증자)
Korean 4.8 KB
2025-09-17 00:00
Share Issue/Capital Change
주요사항보고서(무상증자결정)
Korean 10.2 KB
2025-09-15 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획변경승인) (자큐보정(JP1366)(자스타프라잔시트르산염)의 약물상호작용 확인을 위한…
Korean 11.6 KB
2025-09-05 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB

Automate Your Workflow. Get a real-time feed of all Onconic Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Onconic Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye PCILT
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan 7066
PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan 4587
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden PHAL
Pharos iBio Co., Ltd. Logo
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea 388870
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan 6190
P&K Skin Research Center Co.,Ltd. Logo
Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.
South Korea 347740
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL

Talk to a Data Expert

Have a question? We'll get back to you promptly.